nach oben

AIDS and Behavior

Erschienen in:

01.11.2012 | Original Paper

Correlates of Anxiety in Women Living with HIV of Reproductive Age

verfasst von: Elena L. Ivanova, Trevor A. Hart, Anne C. Wagner, Kinda Aljassem, Mona R. Loutfy

Erschienen in: AIDS and Behavior | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Prior investigations suggest that women living with HIV (WLWH) experience higher rates of anxiety compared to the general population. This study investigates correlates of anxiety among 361 WLWH of reproductive age in Ontario, Canada who completed a series of self-reported measures. Anxiety was assessed using the Hospital Anxiety and Depression Scale (HADS-A). Thirty-seven percent of the sample had high anxiety (HADS-A ≥ 11). HIV-related stigma, reproductive health-related worries, having experienced judgment from family and friends for trying to become pregnant and use of antiretrovirals were associated with high anxiety. Being in a romantic/sexual relationship, older age, and undetectable viral load were associated with low anxiety. Findings highlight the importance of HIV-related stigma and having experienced judgment from family and friends for trying to become pregnant as important predictors of anxiety among WLWH of reproductive age. There is a need for appropriate management of anxiety and stigma for WLWH of childbearing age.

Public Health Agency of Canada. Chapter 5: HIV/AIDS among women in Canada. Available at: http://www.phac-aspc.gc.ca/aids-sida/publication/epi/2010/. Published July, 2010. Accessed 15 Feb 2011.

Centers for Disease Control and Prevention. Estimates of new HIV infections in the United States. Available at: http://www.cdc.gov/hiv/topics/women/index.htm. Updated February 11, 2010. Accessed 15 Feb 2011.

Kaiser Family Foundation. Fact sheet: women and HIV/AIDS in the United States. Available at: http://www.kff.org/hivaids/upload/6092-03.pdf. Published February, 2006. Accessed 3 April 2011.

Savard J, Laberge B, Gauthier JG, Ivers H, Bergeron MG. Evaluating anxiety and depression in HIV-infected patients. J Pers Assess. 1998;71(3):349–67.PubMedCrossRef

Van Servellen G, Sarna L, Nyamathi A, Padilla G, Brecht M, Jablonski KJ. Emotional distress in women with symptomatic HIV disease. Issues Ment Health Nurs. 1998;19(2):173–89.PubMedCrossRef

Andrea H, Bültmann U, Beurskens AJHM, Swaen GMH, Van Schayck CP, Kant IJ. Anxiety and depression in the working population using the HAD scale: psychometrics, prevalence and relationships with psychosocial work characteristics. Soc Psychiatry Psychiatr Epidemiol. 2004;39(8):637–46.PubMedCrossRef

Morrison MF, Petitto JM, Have TT, et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. 2002;159(5):789–96.PubMedCrossRef

Kennedy CA, Skurnick JH, Foley M, Louria DB. Gender differences in HIV-related psychological distress in heterosexual couples. AIDS Care. 1995;7(1):33–8.CrossRef

Cohen MA, Hoffman RG, Cromwell C, et al. The prevalence of distress in persons with human immunodeficiency virus infection. Psychosomatics. 2002;43(1):10–5.PubMedCrossRef

10.

Semple SJ, Patterson TL, Temoshok LR, et al. Identification of psychobiological stressors among HIV-positive women: HIV Neurobehavioral Research Center (HNRC) group. Women Health. 1993;20(4):15–36.PubMed

11.

Bennets A, Shaffer N, Manopaiboon C, et al. Determinants of depression and HIV-related worry among HIV-positive women who have recently given birth, Bangkok, Thailand. Soc Sci Med. 1999;49(6):737–49.CrossRef

12.

Jemmott JB, Miller S. Women’s reproductive decisions in the context of HIV infection. In: O’Leary A, Jemmott LS, editors. Women and AIDS: coping and care. New York: Plenum; 1996. p. 167–84.

13.

Evans DL, Ten Have TR, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002;159(10):1752–9.PubMedCrossRef

14.

Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(3):S123–7.PubMed

15.

Davis S. Clinical sequelae affecting quality of life in the HIV-infected patient. J Assoc Nurses AIDS Care. 2004;15(5):S28–33.CrossRef

16.

Sewell MC, Goggin KJ, Rabkin JG, Ferrando SJ, McElhiney MC, Evans S. Anxiety syndromes and symptoms among men with AIDS: a longitudinal controlled study. Psychosomatics. 2000;41(4):294–300.PubMedCrossRef

17.

Kraaij V, Garnefski N, Schroevers MJ, Van Der Veek SMC, Witlox R, Maes S. Cognitive coping, goal self-efficacy and personal growth in HIV-infected men who have sex with men. Patient Educ Couns. 2008;72(2):301–4.PubMedCrossRef

18.

Dew MA, Becker JT, Sanchez J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med. 1997;27(2):395–409.PubMedCrossRef

19.

Kemppainen JK, Holzemer WL, Nokes K, et al. Self-care management of anxiety and fear in HIV disease. J Assoc Nurses AIDS Care. 2003;14(2):21–9.PubMedCrossRef

20.

Lapedagne T, Ferriere JP, Lacoste D, Verdoux H. Anxiety and depression among HIV-positive subjects: prevalence and risk factors. Ann Med. 2000;158(1):21–32.

21.

Clark RA, Bessinger R. Clinical manifestations and predictors of survival in older women infected with HIV. J Acquir Immune Defic Syndr. 1997;15(5):341–5.CrossRef

22.

Brackis-Cott E, Mellins CA, Dolezal C, Spiegel D. The mental health risk of mothers and children: the role of maternal HIV infection. J Early Adolesc. 2007;27(1):67–89.CrossRef

23.

Catz SL, Gore-Felton C, McClure JB. Psychological distress among minority and low-income women living with HIV. Behav Med. 2002;28(2):53–60.PubMedCrossRef

24.

Loutfy MR, Hart TA, Mohammed SS, et al. Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study. PLoS One. 2009;4(12):e7925.PubMedCrossRef

25.

Ogilvie GS, Palepu A, Remple VP, et al. Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada. AIDS. 2007;21(1):S83–8.PubMedCrossRef

26.

Nattabi B, Li J, Thompson SC, Orach CG, Earnest J. A systematic review of factors influencing fertility desires and intentions among people living with HIV/AIDS: implications for policy and service delivery. AIDS Behav. 2009;13(5):949–68.PubMedCrossRef

27.

Kanniappan S, Jeyapaul MJ, Kalyanwala S. Desire for motherhood: exploring HIV-positive women’s desires, intentions and decision-making in attaining motherhood. AIDS Care. 2008;20(6):625–30.PubMedCrossRef

28.

Ingram D, Hutchinson SA. Double binds and the reproductive and mothering experiences of HIV-positive women. Qual Health Res. 2000;10(1):117–32.PubMedCrossRef

29.

Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Available at: http://www.aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf. Updated May 24, 2010. Accessed 20 Jan 2011.

30.

Wagner AC, Hart TA, Mohammed S, Ivanova E, Wong J, Loutfy MR. Correlates of HIV stigma in HIV-positive women. Arch Womens Ment Health. 2010;13(3):207–14.PubMedCrossRef

31.

Ying Wu D, Munoz M, Espiritu B, et al. Burden of depression among impoverished HIV-postive women in Peru. J Acquir Immune Defic Syndr. 2008;48(4):500–4.CrossRef

32.

Sowell RL, Seal BF, Moneyham L, Demi A, Cohen L, Brake S. Quality of life in HIV-infected women in the south-eastern United States. AIDS Care. 1997;9(5):501–12.PubMedCrossRef

33.

Remis RS, Swantee C, Schiedel L, Merid MF, Liu J. Report on HIV/AIDS in Ontario 2006. Ontario Ministry of Health and Long-Term Care. Available at: http://www.phs.utoronto.ca/ohemu/doc/PHERO2006_report_final.pdf. Published March, 2008. Accessed 15 Jan 2011.

34.

Brislin RW. Back-translation for cross-cultural research. J Cross Cult Psychol. 1970;3(1):185–216.CrossRef

35.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedCrossRef

36.

Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.PubMedCrossRef

37.

Inoue Y, Yamazaki Y, Kihara M, Wadabayashi C, Seki Y, Ichikawa S. The intent and practice of condom use among HIV-positive men who have sex with men in Japan. AIDS Patient Care STDS. 2006;20(11):792–802.PubMedCrossRef

38.

Van der Veek S, Kraaij V, Van Koppen W, Garnefski N, Joekes K. Goal disturbance, cognitive coping and psychological distress in HIV-infected persons. J Health Psychol. 2007;12(2):225–30.PubMedCrossRef

39.

Chandra PS, Deepthivarma S, Jairam KR, Thomas T. Relationship of psychological morbidity and quality of life to illness-related disclosure among HIV-infected persons. J Psychosom Res. 2003;54(3):199–203.PubMedCrossRef

40.

Constantini M, Musso M, Viterbori P, et al. Detecting psychological distress in cancer patients: validity of the Italian version of the hospital anxiety and depression scale. Support Care Cancer. 1999;7(3):121–7.CrossRef

41.

Hall A, A’Hern R, Fallowfield L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer. 1999;35(1):79–85.PubMedCrossRef

42.

Hopwood P, Howell A, Maguire P. Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer. 1991;64(2):349–52.PubMedCrossRef

43.

Pederson SS, Van Domburg RT, Theuns S, Jordaens L, Erdman R. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med. 2004;66(5):714–9.CrossRef

44.

Lam CL, Pan PC, Chan AW, Chan SY, Munro C. Can the hospital anxiety and depression (HAD) scale be used on Chinese elderly in general practice? Fam Pract. 1995;12(2):149–54.PubMedCrossRef

45.

Abiodun OA. A validity study of the hospital anxiety and depression scale in general hospital units and a community sample in Nigeria. Br J Psychiatry. 1994;165(5):669–72.PubMedCrossRef

46.

Berger BE, Ferrans CE, Lashey FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.PubMedCrossRef

47.

PASW Statistics (for Windows) [computer program]. Version 18.0. Chicago: SPSS Inc.; 2009.

48.

Jamshidian M, Bentler PM. ML estimation of mean and covariance structures with missing data using complete data routines. J Educ Behav Stat. 1999;24(1):21–41.

49.

O’Cleirigh C, Hart TA, James CA. HIV and anxiety. In: Zvolensky MJ, Smits JA, editors. Anxiety in health behaviors and physical illness. 1st ed. New York: Springer; 2008. p. 317–40.

50.

Maman S, Medley A; World Health Organization. Gender dimensions of HIV status disclosure to sexual partners: rates, barriers and outcomes: a review paper. Available at: http://www.who.int/gender/documents/en/genderdimensions.pdf. Published 2004. Accessed 1 April 2011.

51.

Robinson FP, Mathews HL, Witek-Janusek L. Stress and HIV disease progression: psychoneuroimmunological framework. J Assoc Nurses AIDS Care. 1999;10(1):21–31.PubMedCrossRef

52.

Perry S, Fishman B, Jacobsberg L, Frances A. Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry. 1992;49(5):396–401.PubMedCrossRef

53.

Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 Cell count decline, and depressive symptoms among HIV-seropositive women longitudinal analysis from the HIV epidemiology research study. JAMA. 2001;285(11):1466–74.PubMedCrossRef

54.

Leserman J, Petitto JM, Gu H, et al. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med. 2002;32(6):1059–73.PubMedCrossRef

55.

Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54(3):295–306.PubMedCrossRef

56.

Reynolds NR, Neidig JL, Wu AW, Gifford AL, Holmes WC. Balancing disfigurement and fear of disease progression: patient perceptions of HIV body fat redistribution. AIDS Care. 2006;18(7):663–73.PubMedCrossRef

57.

Stewart M, Brown J, Donner A, et al. The impact of patient centered care on outcomes. J Fam Pract. 2000;49(9):796–804.PubMed

58.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, text revision. 4th ed. Washington: American Psychiatric Association; 2000.

59.

The People Living with HIV Stigma Index user guide. London, global network of people living with HIV, International Community of Women Living with HIV/AIDS, International Planned Parenthood Federation and Joint United Nations Programme on HIV/AIDS. Available at: http://www.stigmaindex.org/90/publications/the-people-living-with-hiv-stigma-index-userguide.html. Published 2008. Accessed 20 Oct 2011.

60.

Weiss MG, Ramakrishna J, Somma D. Health-related stigma: rethinking concepts and interventions. Psychol Health Med. 2006;11(3):277–87.PubMedCrossRef

Titel: Correlates of Anxiety in Women Living with HIV of Reproductive Age
verfasst von: Elena L. Ivanova
Trevor A. Hart
Anne C. Wagner
Kinda Aljassem
Mona R. Loutfy
Publikationsdatum: 01.11.2012
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 8/2012
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-011-0133-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2012

Sexual Behavior as a Function of Stigma and Coping with Stigma Among People with HIV/AIDS in Rural New England

Stress and Coping in Women Living with HIV: A Meta-Analytic Review

The Relationship Between Positive Psychological Attributes and Psychological Well-Being in Persons with HIV/AIDS

Depressive Symptoms and Their Impact on Health-seeking Behaviors in Newly-diagnosed HIV-infected Patients in Durban, South Africa

Depression, Testosterone Concentration, Sexual Dysfunction and Methadone Use Among Men with Hypogonadism and HIV Infection

Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV